[The use of sulbuthiamine (enerion) in the combined therapy of patients with symptomatic focal epilepsy].
Litvinovich
E F
EF
Langeman
T I
TI
Litvinovich
S F
SF
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D004828:Epilepsies, Partial / Q000188:drug therapy* / Q000191:economics; D005260:Female; D006801:Humans; D008297:Male; D011446:Prospective Studies; D011788:Quality of Life / Q000523:psychology; D012074:Remission Induction; D013831:Thiamine / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use*
D000927:Anticonvulsants; C031331:sulbutiamine; D014635:Valproic Acid; D013831:Thiamine